ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/01/2025
Back to search
Official data from USPTO
STENDRA (AVANAFIL) TABLETS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
12/02/2025
Trademark type
Combined
Nice classes
5
Filing date
01/02/2019
Registration date
05/05/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/05/2020
Last transaction
12/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/23/2019
First use in commerce
10/23/2019
Drawing code
3
Owner type
16
Owner location
CAMPBELL, CA
Examiner
DUBOIS,SUSAN L
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized term "STENDRA" in gray with the appearance of brushed metal. The term "STENDRA" is partially outlined in copper and yellow and includes partial shadowing in gray. A curved line design in the color gray is partially outlined in copper and yellow appears to the right of the term "STENDRA". The gray wording "(AVANAFIL) TABLETS" appears underneath the term "STENDRA".
Holders and representatives
Holders
VIVUS LLC
Metuchen Pharmaceuticals, LLC
Metuchen Pharmaceuticals, LLC
Representatives
Mark Pohl Pharmaceutical Patent Attorneys, LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals for the treatment of erectile dysfunction
Publications
History of USPTO decisions and trademark events.
31 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/31/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/31/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/31/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/31/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/31/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/01/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/31/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/19/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/19/2020
IUAF
USE AMENDMENT FILED
03/02/2020
EISU
TEAS STATEMENT OF USE RECEIVED
03/02/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/01/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2019
PUBO
PUBLISHED FOR OPPOSITION
08/06/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/17/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/03/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
07/01/2019
ALIE
ASSIGNED TO LIE
07/01/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/01/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
07/01/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/01/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/21/2019
GNRT
NON-FINAL ACTION E-MAILED
03/21/2019
CNRT
NON-FINAL ACTION WRITTEN
03/21/2019
DOCK
ASSIGNED TO EXAMINER
03/21/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/24/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/23/2019
NWAP
NEW APPLICATION ENTERED
01/05/2019
Continuous trademark protection
Get notified about every new filing that threatens STENDRA (AVANAFIL) TABLETS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.